Open AccessPreparation and field study of combined vaccine against Clostridium perfringens type A and bovine viral diarrhea virus in camels
Author(s) -
H. A. EL-Helw,
Maha Raafat Abd El Fadeel,
Elham F. El-Sergany,
A. M. Allam,
Mohamed Karam Elbayoumy,
Adel M. El-Kattan,
Alaa A. El-Kholy
Publication year - 2022
Publication title -
clinical and experimental vaccine research
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.958
H-Index - 11
eISSN - 2287-366X
pISSN - 2287-3651
DOI - 10.7774/cevr.2022.11.1.30
Subject(s) - virology , vaccination , clostridium perfringens , inactivated vaccine , medicine , immunization , microbiology and biotechnology , toxoid , virus , neutralization , titer , duck embryo vaccine , immune system , biology , immunology , rabies virus , tetanus , bacteria , genetics
The key objective of this study was to formulate a local combined inactivated gel adjuvanted vaccine containing bovine viral diarrhea virus (BVDV)-1, BVDV-2 viruses and Clostridium perfringens type A toxoid. The study evaluated its ability to enhance protective active immune response in camels' calves against these infectious pathogens under field conditions.